Cara Therapeutics (CARA) R&D US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D, bln rub | 107.9 | 82.7 | 91.9 | 108.5 | 108.5 | 88.0 | |||
Changes by years, y/y, % | -5% | -23% | +11% | +18% | 0% | +7.5% |
Cara Therapeutics. R&D, bln rub
Cara Therapeutics. R&D, changes, %
Cara Therapeutics. R&D, sum by quarters, bln rub
Cara Therapeutics (CARA) R&D US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
R&D, bln rub | 25.5 | 28.4 | 28.4 | 22.0 | 9.31 | 88.0 | ||
Changes by years, y/y, % | +3% | +9% | +9% | -10% | -69% | |||
Changes by quarters, q/q, % | -16% | +12% | 0% | -23% | -58% |